Immuron Limited (IMRN)
NASDAQ: IMRN · IEX Real-Time Price · USD
2.640
-0.080 (-2.94%)
At close: Jul 19, 2024, 12:00 AM
2.760
+0.120 (4.55%)
Pre-market: Jul 22, 2024, 9:13 AM EDT
Immuron Employees
Immuron had 6 employees as of June 30, 2023. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
$405,515
Profits / Employee
-$440,057
Market Cap
15.05M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 6 | 1 | 20.00% |
Jun 30, 2022 | 5 | -11 | -68.75% |
Jun 30, 2014 | 16 | 8 | 100.00% |
Jun 30, 2013 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Centogene | 384 |
BIMI International Medical | 296 |
Star Equity Holdings | 171 |
Flora Growth | 108 |
Talis Biomedical | 99 |
Evaxion Biotech | 49 |
Edesa Biotech | 16 |
BriaCell Therapeutics | 16 |
IMRN News
- 20 days ago - Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewsWire
- 6 weeks ago - Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference - GlobeNewsWire
- 7 weeks ago - Immuron Board Changes - GlobeNewsWire
- 7 weeks ago - Immuron CEO Steven Lydeamore to present at Peak Sky High - GlobeNewsWire
- 2 months ago - Immuron Limited to Present at the Emerging Growth Conference - GlobeNewsWire
- 2 months ago - Immuron Director Resignation - GlobeNewsWire
- 3 months ago - Immuron to host Live Virtual Event - GlobeNewsWire
- 3 months ago - Immuron Travelan® sales continued strong growth - GlobeNewsWire